Bharat Biotech’s Covaxin has been approved by the WHO, with the technical advisory team recommending the India-made vaccine for emergency use in anyone aged 18 and up.
Highlights:
This is a significant step forward in India’s fight against Covid-19.
Covaxin is a vaccine developed by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
It is totally “made in India.” Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson Janssen, Moderna, and Sinopharm have all had their Covid-19 Vaccines authorized by the WHO for emergency use.
Last month, the technical advisory panel requested additional clarity from Bharat Biotech for its final risk assessment, which caused the emergency listing to be postponed.
Covaxin has been recommended for emergency use listing by the technical advisory group, which met to make the final decision.